. 2021 Mar 17;7(1):e26950. doi: 10.2196/26950
©Andreas Trojan, Basil Bättig, Meinrad Mannhart, Burkhardt Seifert, Mathis N Brauchbar, Marco Egbring. Originally published in JMIR Cancer (http://cancer.jmir.org), 17.03.2021.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Cancer, is properly cited. The complete bibliographic information, a link to the original publication on http://cancer.jmir.org/, as well as this copyright and license information must be included.
Figure 2.
Frequency of the most commonly applied anticancer therapies during Consilium app use.